Denmark's Julius Johansen was the last rider to start the opening stage of O Gran Camiño, a 14.8-kilometre individual time ...
(Evenity), burosumab (Crysvita), ixekizumab (Taltz), elotuzumab (Empliciti), isatuximab (Sarclisa), nirsevimab (Beyfortus), and tremelimumab (Imjudo), and released a recombinant monoclonal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results